Press Release

United States Digital Therapeutics Market to Grow with a CAGR of 21.15% through 2028

Adoption of telehealth & remote patient monitoring systems and increasing incorporation of digital health technology in mental health expected to drive the United States Digital Therapeutics Market growth in the forecast period, 2024-2028. 


According to TechSci Research report, “United States Digital Therapeutics Market –Industry Size, Share, Trends, Competition Forecast & Opportunities, 2018-2028F”, the United States Digital Therapeutics Market stood at USD 1.45 Billion in 2022 and is anticipated to project steady growth in the forecast period with a CAGR of 21.15% through 2028. The United States Digital Therapeutics Market is experiencing significant growth, driven by several key factors. The heightened prevalence of chronic diseases, such as diabetes and cardiovascular conditions, has created a pressing need for innovative solutions to manage and treat these conditions effectively. There is a growing focus on preventive healthcare, with individuals and healthcare providers recognizing the importance of early intervention and proactive measures to maintain health and well-being. Moreover, the upsurge in smartphone and internet usage has provided a fertile ground for digital therapeutics to thrive. These technologies leverage the power of mobile devices and connectivity to deliver personalized and accessible healthcare solutions to individuals anytime, anywhere. This convenience and accessibility have revolutionized the way healthcare is delivered, empowering individuals to take control of their health and engage in self-care.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "United States Digital Therapeutics Market.”


The United States Digital Therapeutics Market refers to the rapidly growing and evolving industry that leverages digital and online health technologies to treat a wide range of medical and psychological conditions. Within this burgeoning field, cutting-edge digital tools and software, including mobile apps, wearable devices, and telemedicine platforms, are utilized to provide innovative therapeutic interventions that aim to improve health outcomes. These interventions have the potential to prevent, manage, and treat a broad spectrum of physical, mental, and behavioral conditions, catering to the diverse and unique needs of individuals. With the increasing pace of technological advancements and a rise in healthcare spending, coupled with the growing prevalence of chronic diseases, the market for digital therapeutics is poised for significant growth and transformation. As more individuals embrace and adopt these digital solutions, the possibilities for improving healthcare delivery and patient outcomes are expanding, paving the way for a healthier and more connected future. Digital therapeutics are revolutionizing the healthcare landscape by offering personalized and accessible interventions that can be easily integrated into individuals' daily lives. By combining technology and evidence-based medicine, this field is at the forefront of innovation, providing opportunities for improved patient engagement, treatment adherence, and long-term health management. With continuous advancements in digital therapeutics, the potential for targeted and precise interventions tailored to individual needs is further enhanced, making it an exciting and promising area of healthcare.

As the digital therapeutics market continues to evolve, new developments are emerging to enhance the efficacy and reach of these interventions. For example, artificial intelligence and machine learning algorithms are being employed to analyze vast amounts of patient data and provide personalized treatment recommendations. Virtual reality and augmented reality technologies are also being integrated into digital therapeutics to create immersive and interactive experiences that enhance the effectiveness of interventions. Moreover, the integration of digital therapeutics with other healthcare technologies, such as electronic health records and remote monitoring devices, is enabling seamless data exchange and real-time monitoring of patients' progress. This integration facilitates more comprehensive and personalized care, enabling healthcare providers to make informed decisions and adjustments to treatment plans based on real-time data and insights. The future of digital therapeutics holds great promise, with the potential to revolutionize healthcare delivery and improve patient outcomes on a global scale. As the industry continues to innovate and expand, it is expected that digital therapeutics will become an integral part of standard medical practice, complementing traditional therapies and providing new avenues for preventive care and personalized treatment. The United States Digital Therapeutics Market is a dynamic and rapidly growing industry that leverages digital technologies to provide innovative therapeutic interventions for a wide range of medical and psychological conditions. With advancements in digital tools, artificial intelligence, and integration with other healthcare technologies, digital therapeutics hold immense potential to transform healthcare delivery and improve patient outcomes. As the market continues to evolve, it is an exciting and promising area of healthcare that offers personalized and accessible interventions tailored to individual needs, paving the way for a healthier future. The United States Digital Therapeutics Market is segmented into product, sales channel, application, regional distribution, and company. Based on application, The Digital Therapeutics market is predominantly dominated by Preventive Applications, which play a crucial role in addressing the escalating costs of healthcare. With a growing emphasis on preventive healthcare, there is an ever-increasing demand for applications that can effectively monitor health conditions and provide valuable suggestions to prevent potential health issues. This proactive approach has proven to be remarkably effective in managing chronic diseases and mitigating future health risks, making it the preferred choice among users who prioritize their well-being and long-term health. By leveraging the power of technology, these preventive applications empower individuals to take control of their health and make informed decisions to lead healthier and happier lives.

Based on region, the West region is playing a pivotal role in driving the growth of the US Digital Therapeutics Market, fueled by a confluence of several key factors. Firstly, this region boasts a vibrant ecosystem of leading technology corporations and startups, fostering an environment that is conducive to continuous innovation and cutting-edge advancements in digital therapeutics. Moreover, the presence of esteemed educational institutions in the West region contributes to a strong emphasis on research and development in the field of digital therapeutics, further propelling its growth. Additionally, the West region benefits from a higher concentration of tech-savvy individuals, who are not only more receptive to digital solutions but also actively seek out innovative healthcare options. This, coupled with the region's robust healthcare infrastructure, ensures the swift adoption and widespread acceptance of digital therapeutics solutions. The West region truly serves as a hub of technological innovation and collaboration, driving the advancement of digital therapeutics and revolutionizing the way healthcare is delivered and experienced.


Major companies operating in the United States Digital Therapeutics Market are:

  • Noom Inc.
  • Omada Health Inc.
  • WellDoc, Inc.
  • Pear Therapeutics Inc.
  • Proteus Digital Health Inc.
  • Resmed, Inc. (Propeller Health)
  • Akili Interactive Labs, Better Therapeutics
  • 2Morrow Inc.
  • Ginger, Fitbit Inc. (Twin Health Inc.)
  • Livongo Health, Inc.


Download Free Sample Report

Customers can also request 10% free customization on this report.


“The future of the United States Digital Therapeutics Market is poised for significant growth. The increasing prevalence of chronic diseases, such as diabetes and cardiovascular conditions, creates a pressing need for innovative solutions that can effectively manage and treat these conditions. Additionally, the surge in preventive healthcare, with individuals becoming more proactive in managing their health and well-being, further drives the demand for digital therapeutics. Technological advancements in artificial intelligence, machine learning, and big data analytics play a crucial role in the growth of the digital therapeutics market. These technologies enable the development of sophisticated algorithms and predictive models that can analyze vast amounts of patient data, leading to more accurate diagnoses and tailored treatment plans. Furthermore, strategic collaborations between digital therapeutic startups and pharmaceutical companies are anticipated to unlock new avenues for market expansion. By combining expertise and resources, these partnerships can accelerate the development and commercialization of innovative digital therapeutic solutions. The future of the United States Digital Therapeutics Market is promising, with immense potential to revolutionize healthcare delivery and improve patient outcomes. As technology continues to advance and regulatory frameworks evolve, digital therapeutics are expected to play an increasingly vital role in the management of chronic diseases and the overall transformation of healthcare.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

United States Digital Therapeutics Market By Product (Software, Device), By Sales Channel (B2B, B2C), By Application (Preventive Applications, Treatment Applications), By Region, Competition, Forecast and& Opportunities, 2018-2028F”, has evaluated the future growth potential of United States Digital Therapeutics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Digital Therapeutics Market.


Mr. Ken Mathews         

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656                                                     

Email: [email protected]